News
Learn what drives our clients and us.
Client and Agency News
SHS invests in molecular diagnostics specialist GNA Biosolutions
The fund SHS IV has invested in GNA Biosolutions GmbH together with existing and new investors. GNA, a manufacturer of ultrafast pathogen diagnostic instruments, will receive fresh [...]
numares technology offers performance and robustness: 500,000 lipoprotein tests in US laboratory
The U.S. based laboratory HEALTH DIAGNOSTIC LABORATORY, Inc. (HDL, Inc.) has performed 500,000 tests for the determination of lipoproteins since the first devices were installed at HDL, [...]
numares announces lipoFIT-S100 market launch
World's first CE-labeled NMR-based in-vitro diagnostic system - This enables diagnostic and research laboratories to measure LP particle concentrations on their own and add advanced lipoprotein analyses [...]
SHS invests in robotic surgery company AOT
With its fourth fund, Tübingen-based growth investor SHS Gesellschaft für Beteiligungsmanagement has invested in Swiss AOT AG. AOT develops, produces and markets computer assisted laser systems for [...]
SHS invests in cardiology specialist Vimecon
The fourth fund of the Tübingen based growth investor SHS Gesellschaft für Beteiligungsmanagement has invested in Vimecon GmbH together with existing and new investors. Founded in 2005, [...]
RIEMSER Pharma appoints Dr. Thomas Werner to its Advisory Board
RIEMSER Pharma GmbH has appointed Dr. Thomas Werner (58) to its Advisory Board. The former head of GlaxoSmithKline and Bristol-Myers Squibb Germany will primarily support RIEMSER in [...]